Aktieselskabet Schouw & Co.
20.4.2026 15:00:00 CEST | Globenewswire | Press release
Schouw & Co. share buy-back programme, week 16 2026
Schouw & Co. share buy-back programme, week 16 2026
On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
| Trading day | No. of shares | Average price | Amount DKK | ||
| Accumulated until 10 April 2026 | 108,283 | 668.20 | 72,355,013 | ||
| Monday, 13 April 2026 | 1,000 | 668.00 | 668,000 | ||
| Tuesday, 14 April 2026 | 1,000 | 676.97 | 676,970 | ||
| Wednesday, 15 April 2026 | 1,000 | 669.00 | 669,000 | ||
| Thursday, 16 April 2026 | 1,000 | 665.00 | 665,000 | ||
| Friday, 17 April 2026 | 1,000 | 663.23 | 663,233 | ||
| In the period 13 April 2026 - 17 April 2026 | 5,000 | 668.44 | 3,342,203 | ||
| Accumulated until 17 April 2026 | 113,283 | 668.21 | 75,697,216 | ||
| Following the above transactions, Schouw & Co. holds a total of 2,351,076 treasury shares corresponding to 9.40% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Jyske Bank20.4.2026 16:06:01 CEST | Press release
Extraordinary General Meeting of Jyske Bank A/S held on 20 April 2026
Jyske Bank20.4.2026 16:06:01 CEST | Pressemeddelelse
Ekstraordinær generalforsamling i Jyske Bank A/S den 20. april 2026
BVI Medical, Inc.20.4.2026 16:00:00 CEST | Press release
BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform
SJF Bank A/S20.4.2026 15:43:46 CEST | Pressemeddelelse
Gennemførsel af kapitalnedsættelse
Orion Oyj20.4.2026 15:00:00 CEST | Press release
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom